MediWound (MDWD) Total Current Liabilities (2013 - 2026)
MediWound (MDWD) posted Total Current Liabilities of $18.5 million for Q2 2026, down 14.34% on a QoQ basis from $21.6 million in Q1 2026, and down 36.21% year-over-year from $29.1 million in Q2 2025.
Analysis
MediWound (MDWD) Total Current Liabilities (2013 - 2026) Analysis & Trends
MediWound has reported Total Current Liabilities for 13 years, with the latest figure at $18.5 million in Q2 2026.
- On a quarterly basis, Total Current Liabilities fell 36.21% year-over-year to $18.5 million in Q2 2026; TTM through Jun 2026 was $18.5 million, a 36.21% decrease from a year earlier, with the FY2025 full-year figure at $25.7 million, down 3.14% from the prior year.
- Total Current Liabilities was $18.5 million for Q2 2026 at MediWound, down from $21.6 million in the prior quarter.
- The five-year high for Total Current Liabilities was $29.1 million in Q2 2025, with the low at $9.0 million in Q3 2022.
- Average Total Current Liabilities over 5 years is $20.0 million, with a median of $21.7 million recorded in 2025.
- The sharpest annual moves came in 2023 and 2026: Total Current Liabilities soared 112.78% in 2023, then plunged 36.21% in 2026.
- Over 5 years, Total Current Liabilities stood at $12.1 million in 2022, then jumped by 50.33% to $18.1 million in 2023, then soared by 46.43% to $26.5 million in 2024, then declined by 3.14% to $25.7 million in 2025, then declined by 27.87% to $18.5 million in 2026.
- The last three Total Current Liabilities figures came in at $18.5 million (Q2 2026), $21.6 million (Q1 2026), and $25.7 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | 25.50 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | 11.02 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | 3.94 Bn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | 5.53 Bn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | 1.58 Bn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | 2.53 Bn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | 1.51 Bn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | 3.92 Bn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | 283.60 Mn |
| 10 | MediWound | 156.09 Mn | 120.75 Mn | 337,000.00 | 18.54 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 18.54 Mn |
| Mar 31, 2026 | 21.65 Mn |
| Dec 31, 2025 | 25.71 Mn |
| Sep 30, 2025 | 26.25 Mn |
| Jun 30, 2025 | 29.07 Mn |
| Mar 31, 2025 | 21.84 Mn |
| Dec 31, 2024 | 26.54 Mn |
| Sep 30, 2024 | 25.58 Mn |
| Jun 30, 2024 | 22.61 Mn |
| Mar 31, 2024 | 22.34 Mn |
| Dec 31, 2023 | 18.13 Mn |
| Sep 30, 2023 | 17.34 Mn |
| Jun 30, 2023 | 17.99 Mn |
| Mar 31, 2023 | 23.94 Mn |
| Dec 31, 2022 | 12.06 Mn |
| Sep 30, 2022 | 9.01 Mn |
| Jun 30, 2022 | 10.42 Mn |
| Mar 31, 2022 | 11.25 Mn |
| Dec 31, 2021 | 10.72 Mn |
| Sep 30, 2021 | 9.96 Mn |